|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 542.32 USD | -0.92% |
|
-5.74% | +3.90% |
| Capitalization | 192B 164B 153B 144B 265B 17,413B 290B 1,786B 693B 8,208B 721B 706B 29,946B | P/E ratio 2025 * |
71.9x | P/E ratio 2026 * | 62x |
|---|---|---|---|---|---|
| Enterprise value | 187B 160B 149B 140B 258B 16,959B 282B 1,739B 675B 7,994B 703B 688B 29,166B | EV / Sales 2025 * |
18.9x | EV / Sales 2026 * | 16.2x |
| Free-Float |
99.33% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Intuitive Surgical, Inc.
| 1 day | -0.92% | ||
| 1 week | -5.74% | ||
| Current month | -5.43% | ||
| 1 month | -4.10% | ||
| 3 months | +20.60% | ||
| 6 months | +5.88% | ||
| Current year | +3.90% |
| 1 week | 537.69 |  | 576.15 |
| 1 month | 537.69 | | 582.41 |
| Current year | 425 | | 616 |
| 1 year | 425 | | 616 |
| 3 years | 222.65 | | 616 |
| 5 years | 180.07 | | 616 |
| 10 years | 55.78 | | 616 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Rosa Rosa
CEO | Chief Executive Officer | 57 | 2025-06-30 |
Jamie Samath
DFI | Director of Finance/CFO | 54 | 2021-12-31 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Guthart
CHM | Chairman | 59 | 2025-06-30 |
Mark Rubash
BRD | Director/Board Member | 67 | 2007-10-18 |
Dave Rosa Rosa
BRD | Director/Board Member | 57 | 2024-07-23 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.76% | 26 M€ | +12.27% | - |
| 1.86% | 148 M€ | +19.11% | - |
| 1.52% | 160 M€ | +15.18% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.92% | -5.74% | +0.51% | +92.49% | 192B | |
| -1.14% | -0.09% | +8.61% | +0.16% | 215B | |
| -2.60% | +0.04% | -3.64% | -18.20% | 160B | |
| +0.90% | -5.07% | +2.74% | +96.14% | 137B | |
| +0.98% | +1.33% | -17.59% | -13.52% | 57.67B | |
| -1.38% | -3.61% | +13.31% | +9.37% | 48.21B | |
| -2.23% | -3.99% | +0.49% | -11.40% | 39.54B | |
| -2.43% | -1.76% | +3.53% | - | 38.25B | |
| -0.05% | -1.67% | +5.76% | +12.77% | 36.77B | |
| +2.07% | -1.27% | -22.90% | -36.04% | 34.25B | |
| Average | -0.68% | -2.07% | -0.92% | +14.64% | 95.91B | |
| Weighted average by Cap. | -0.87% | -2.29% | +0.99% | +28.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 9.93B 8.46B 7.9B 7.43B 13.68B 899B 14.95B 92.19B 35.76B 424B 37.24B 36.46B 1,546B | 11.43B 9.73B 9.09B 8.56B 15.75B 1,035B 17.21B 106B 41.17B 488B 42.87B 41.97B 1,780B |
| Net income | 2.73B 2.32B 2.17B 2.04B 3.76B 247B 4.11B 25.35B 9.83B 117B 10.24B 10.02B 425B | 3.2B 2.73B 2.55B 2.4B 4.41B 290B 4.82B 29.71B 11.53B 137B 12B 11.75B 498B |
| Net Debt | -5.01B -4.27B -3.99B -3.75B -6.91B -454B -7.55B -46.54B -18.05B -214B -18.8B -18.41B -781B | -7.57B -6.45B -6.03B -5.67B -10.44B -686B -11.4B -70.33B -27.28B -323B -28.41B -27.81B -1,180B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 542.32 $ | -0.92% | 2,116,297 |
| 25-12-11 | 547.36 $ | -1.54% | 1,573,821 |
| 25-12-10 | 555.92 $ | -0.40% | 1,563,110 |
| 25-12-09 | 558.13 $ | -1.55% | 1,229,982 |
| 25-12-08 | 566.89 $ | -1.47% | 1,298,899 |
Delayed Quote Nasdaq, December 12, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ISRG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition